Corrigendum to “Molecular regulation of urea cycle function by the liver glucocorticoid receptor” [Mol Metab 4 (10) (2015 Oct) 732–740] ( Molecular Metabolism (2015) 4(10) (732–740), (S2212877815001404), (10.1016/j.molmet.2015.07.006));Molecular regulation of urea cycle function by the liver glucocorticoid receptor

Molecular Metabolism

Volumn 4, Issue 10, 2015, Pages 732-740

  Okun, Jürgen G ^a   Conway, Sean ^a   Schmidt, Kathrin V ^a   Schumacher, Jonas ^a   Wang, Xiaoyue ^a   de Guia, Roldan ^a   Zota, Annika ^a,c   Klement, Johanna ^b   Seibert, Oksana ^a   Peters, Achim ^b   Maida, Adriano ^a,c   Herzig, Stephan ^a,c   Rose, Adam J ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Amino acid; Metabolism; Protein; Stress

Indexed keywords

ACYLCARNITINE; AMINO ACID; ARGINASE 1; DEXAMETHASONE; DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; UREA;

ADDISON DISEASE; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA BINDING; EX VIVO STUDY; GENE TARGETING; HUMAN; HUMAN EXPERIMENT; HYPERAMMONEMIA; IN VIVO STUDY; LIVER; METABOLIC REGULATION; MOUSE; MUSCLE ATROPHY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; UPREGULATION; UREA BLOOD LEVEL; UREA CYCLE DISORDER;

EID: 84942198632     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2020.101068     Document Type: Erratum

References (55)

1. Overman R.A., Yeh J.Y., Deal C.L. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care & Research (Hoboken) 2013, 65(2):294-298.
2. Rose A.J., Vegiopoulos A., Herzig S. Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. The Journal of Steroid Biochemistry and Molecular Biology 2010, 122(1-3):10-20.
3. Kleiman A., Tuckermann J.P. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Molecular Cell Endocrinology 2007, 275(1-2):98-108.
4. Magomedova L., Cummins C.L. Glucocorticoids and metabolic control. Handbook of Experimental Pharmacology 2015.
5. Schimmer B.P., Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. The pharmacological basis of therapeutics 1996, 1459-1485. McGraw-Hill, New York. 9th ed. J.G. Hardman, L.E. Limbird (Eds.).
6. Opherk C., Tronche F., Kellendonk C., Kohlmüller D., Schulze A., Schmid W., et al. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Molecular Endocrinology 2004, 18(6):1346-1353.
7. Reichardt S.D., Foller M., Rexhepaj R., Pathare G., Minnich K., Tuckermann J.P., et al. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes. Endocrinology 2012, 153(4):1783-1794.
8. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413(6852):179-183.
9. de Guia R.M., Rose A.J., Sommerfeld A., Seibert O., Strzoda D., Zota A., et al. microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis. The EMBO Journal 2015, 34(3):344-360.
10. Lemke U., Krones-Herzig A., Berriel Diaz M., Narvekar P., Ziegler A., Vegiopoulos A., et al. The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metabolism 2008, 8(3):212-223.
11. Watson M.L., Baehr L.M., Reichardt H.M., Tuckermann J.P., Bodine S.C., Furlow J.D. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. American Journal of Physiology. Endocrinology and Metabolism 2012, 302(10):E1210-E1220.
12. Hu Z., Wang H., Lee I.H., Du J., Mitch W.E. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. The Journal of Clinical Investigation 2009, 119(10):3059-3069.
13. Rose A.J., Berriel Diaz M., Reimann A., Klement J., Walcher T., Krones-Herzig A., et al. Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metabolism 2011, 14(1):123-130.
14. Rauch A., Seitz S., Baschant U., Schilling A.F., Illing A., Stride B., et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metabolism 2010, 11(6):517-531.
15. de Kloet A.D., Krause E.G., Solomon M.B., Flak J.N., Scott K.A., Kim D.H., et al. Adipocyte glucocorticoid receptors mediate fat-to-brain signaling. Psychoneuroendocrinology 2015, 56:110-119.
16. Shimizu N., Maruyama T., Yoshikawa N., Matsumiya R., Ma Y., Ito N., et al. A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling. Nature Communications 2015, 6:6693.
17. Kellendonk C., Eiden S., Kretz O., Schutz G., Schmidt I., Tronche F., et al. Inactivation of the GR in the nervous system affects energy accumulation. Endocrinology 2002, 143(6):2333-2340.
18. Klement J., Hubold C., Cords H., Oltmanns K.M., Hallschmid M., Born J., et al. High-calorie glucose-rich food attenuates neuroglycopenic symptoms in patients with Addison's disease. The Journal of Cinical Endocrinology and Metabolism 2010, 95(2):522-528.
19. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998, 93(4):531-541.
20. Tronche F., Opherk C., Moriggl R., Kellendonk C., Reimann A., Schwake L., et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes & Development 2004, 18(5):492-497.
21. Gray S., Wang B., Orihuela Y., Hong E.G., Fisch S., Haldar S., et al. Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metabolism 2007, 5(4):305-312.
22. Domanskyi A., Alter H., Vogt M.A., Gass P., Vinnikov I.A. Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance. Frontiers in Cellular Neuroscience 2014, 8:275.
23. de Graaf I.A., Olinga P., de Jager M.H., Merema M.T., de Kanter R., van de Kerkhof E.G., et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nature Protocols 2010, 5(9):1540-1551.
24. Patti M.E., Brambilla E., Luzi L., Landaker E.J., Kahn C.R. Bidirectional modulation of insulin action by amino acids. The Journal of Clinical Investigation 1998, 101(7):1519-1529.
25. Wei L.H., Wu G., Morris S.M., Ignarro L.J. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(16):9260-9264.
26. Graham T., McIntosh J., Work L.M., Nathwani A., Baker A.H. Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats. Genetic Vaccines and Therapy 2008, 6:9.
27. Sauer S.W., Okun J.G., Fricker G., Mahringer A., Muller I., Crnic L.R., et al. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Journal of Neurochemistry 2006, 97(3):899-910.
28. Rose A.J., Alsted T.J., Kobbero J.B., Richter E.A. Regulation and function of Ca2+-calmodulin-dependent protein kinase II of fast-twitch rat skeletal muscle. The Journal of Physiology 2007, 580(Pt.3):993-1005.
29. Grontved L., John S., Baek S., Liu Y., Buckley J.R., Vinson C., et al. C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. The EMBO Journal 2013, 32(11):1568-1583.
30. Langmead B. Aligning short sequencing reads with bowtie. Curr protoc bioinformatics 2010, [Chapter 11]: p. Unit 11 7.
31. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., et al. Model-based analysis of ChIP-Seq (MACS). Genome Biology 2008, 9(9):R137.
32. Robinson J.T., Thorvaldsdottir H., Winckler W., Guttman M., Lander E.S., Getz G., et al. Integrative genomics viewer. Nature Biotechnology 2011, 29(1):24-26.
33. Meijer A.J., Lamers W.H., Chamuleau R.A. Nitrogen metabolism and ornithine cycle function. Physiological Reviews 1990, 70(3):701-748.
34. Gropman A.L., Summar M., Leonard J.V. Neurological implications of urea cycle disorders. Journal of Inherited Metabolic Disease 2007, 30(6):865-879.
35. Lim H.W., Uhlenhaut N.H., Rauch A., Weiner J., Hubner S., Hubner N., et al. Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo. Genome Research 2015, 25(6):836-844.
36. Jantzen H.M., Strahle U., Gloss B., Stewart F., Schmid W., Boshart M., et al. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 1987, 49(1):29-38.
37. Sigsgaard I., Almdal T., Hansen B.A., Vilstrup H. Dexamethasone increases the capacity of urea synthesis time dependently and reduces the body weight of rats. Liver 1988, 8(4):193-197.
38. Grofte T., Jensen D.S., Gronbaek H., Wolthers T., Jensen S.A., Tygstrup N., et al. Effects of growth hormone on steroid-induced increase in ability of urea synthesis and urea enzyme mRNA levels. American Journal of Physiology 1998, 275(1 Pt 1):E79-E86.
39. Wolthers T., Hamberg O., Grofte T., Vilstrup H. Effects of budesonide and prednisolone on hepatic kinetics for urea synthesis. Journal of Hepatology 2000, 33(4):549-554.
40. Heindorff H., Almdal T.P., Vilstrup H. Blockade of glucocorticoid receptors prevents the increase in urea synthesis after hysterectomy in rats. European Journal of Clinical Investigation 1991, 21(6):625-630.
41. Heindorff H.A. The hepatic catabolic stress response. Hormonal regulation of urea synthesis after surgery. Danish Medical Bulletin 1993, 40(2):224-234.
42. Caparroz-Assef S.M., Bersani-Amado C.A., Kelmer-Bracht A.M., Bracht A., Ishii-Iwamoto E.L. The metabolic changes caused by dexamethasone in the adjuvant-induced arthritic rat. Molecular and Cellular Biochemistry 2007, 302(1-2):87-98.
43. Iyer R.K., Yoo P.K., Kern R.M., Rozengurt N., Tsoa R., O'Brien W.E., et al. Mouse model for human arginase deficiency. Molecular and Cellular Biology 2002, 22(13):4491-4498.
44. Kasten J., Hu C., Bhargava R., Park H., Tai D., Byrne J.A., et al. Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. Molecular Genetics and Metabolism 2013, 110(3):222-230.
45. Lee E.K., Hu C., Bhargava R., Rozengurt N., Stout D., Grody W.W., et al. Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy. Molecular Therapy: The Journal of the American Society of Gene Therapy 2012, 20(10):1844-1851.
46. Ulbright C., Snodgrass P.J. Coordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanisms. Archives of Biochemistry and Biophysics 1993, 301(2):237-243.
47. Gotoh T., Chowdhury S., Takiguchi M., Mori M. The glucocorticoid-responsive gene cascade. Activation of the rat arginase gene through induction of C/EBPbeta. The Journal of Biological Chemistry 1997, 272(6):3694-3698.
48. Kimura T., Chowdhury S., Tanaka T., Shimizu A., Iwase K., Oyadomari S., et al. CCAAT/enhancer-binding protein beta is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary-cultured hepatocytes. FEBS Letters 2001, 494(1-2):105-111.
49. Phuc Le P., Friedman J.R., Schug J., Brestelli J.E., Parker J.B., Bochkis I.M., et al. Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genetics 2005, 1(2):e16.
50. Miranda T.B., Morris S.A., Hager G.L. Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor. Molecular and Cellular Endocrinology 2013, 380(1-2):16-24.
51. Tannour-Louet M., York B., Tang K., Stashi E., Bouguerra H., Zhou S., et al. Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis. Molecular Endocrinology 2014, 28(10):1707-1718.
52. Swali A., Walker E.A., Lavery G.G., Tomlinson J.W., Stewart P.M. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets. Diabetologia 2008, 51(11):2003-2011.
53. Wise J.K., Hendler R., Felig P. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. The Journal of Clinical Investigation 1973, 52(11):2774-2782.
54. Magnusson I., Rothman D.L., Katz L.D., Shulman R.G., Shulman G.I. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. The Journal of Clinical Investigation 1992, 90(4):1323-1327.
55. Jungas R.L., Halperin M.L., Brosnan J.T. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiological Reviews 1992, 72(2):419-448.